WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 26'0001 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 30'5971 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 1'129  1'117  1'104  1'091  1'077  943  767  685 
Births 13  13  13  13  13  13  15  14 
Surviving infants 13  13  13  13  13  12  15  13 
Pop. less than 5 years 65  65  64  63  62  68  70  60 
Pop. less than 15 years 195  195  196  199  201  211  195  171 
Female 15-49 years 289  286  284  281  278  244  192  178 

Number of reported case

(Click for retrospective incidence data for Cyprus)
Diphtheria
Japanese encephalitis
Measles 18 
Mumps
Pertussis 16 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cyprus)
Vaccine year result method % card seen                                                
BCG         
DTP1          100  100  100  100  100  100 
DTP3          99  99  99  99  97  97  34 
HepB_BD          95 
HepB3          96  96  96  96  93  89 
Hib3          96  96  96  96  90  32 
JapEnc         
MCV          86  87  87  87  87  86  29 
MCV2          88  88  89 
PCV1          97 
PCV3         
Pol3          99  99  99  99  97  97  35 
Rota1         
Rota_last         
Rubella1          86  87  87  87  87 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cyprus)
DTP1 99  99  99  99  98  98  97  59 
DTP3 99  99  99  99  97  97  93  34 
HepB3 96  96  96  96  93  89 
Hib3 96  96  96  96  90  32 
MCV 86  87  87  87  87  86  77  29 
PCV3
Pol3 99  99  99  99  97  97  94  35 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 17
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
16
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Given only to children with continuous contact with a contagious form of TB
DTaPHibHepIPV 2, 4, 6 months; Yes
DTaPHibIPV 2, 4, 6, 15-18 months; Yes
DTaPIPV 2, 4, 6, 15-18 months; 4-6 years; Yes
HepA Yes high risk groups
HepB 2, 4, 8-12 months; Yes
Hib 2, 4, 6, 12-18 months; Yes
IPV 2, 4, 6, 15-18 months; 4-6 years; Yes
MMR 13-15 months; 4-6 years; Yes
MenC_conj 12-15 months; Yes
Pneumo_conj 2, 4, 6, 12-15 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2'013    2'012  2'011  2'010  2'010  2'010 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 83  83  83  83  83  83  83 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 17  33  33  17  33     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR     Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND     No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%     21  40  10  36  36 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.